Fosaprepitant Dimeglumine Suppliers & Bulk Manufacturers

Available Forms: Injection (IV)

Available Strengths: 150 mg/vial

Reference Brands: Emend® IV (EU & US)

Category: Oncology Cancer Care

Fosaprepitant Dimeglumine is available in Injection (IV) and strengths such as 150 mg/vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fosaprepitant Dimeglumine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Fosaprepitant Dimeglumine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Fosaprepitant Dimeglumine is a trusted NK1 receptor antagonist used in oncology supportive care to prevent chemotherapy-induced nausea and vomiting (CINV). Available as a 150 mg intravenous injection, Fosaprepitant is commonly co-administered with 5-HT3 antagonists and corticosteroids. It enhances patient comfort and compliance during highly or moderately emetogenic chemotherapy. Approved in both the US and EU, and marketed under Emend® IV and as generics, it is widely used in hospital oncology departments and pharma B2B distribution. Reliable and effective, Fosaprepitant plays a critical role in managing CINV, improving quality of life for cancer patients receiving chemotherapy.